Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort

British Journal of Dermatology

Volumn 168, Issue 6, 2013, Pages 1303-1310

  Danielsen, K ^a,b   Olsen, A O ^c,d   Wilsgaard, T ^b   Furberg, A S ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; LEISURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SELF REPORT; SMOKING; TREND STUDY;

ADULT; AGED; COHORT STUDIES; DIAGNOSTIC SELF EVALUATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NORWAY; PREVALENCE; PSORIASIS; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84878630437     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12230     Document Type: Article

References (46)

1. Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-9.
2. Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-6.
3. Gupta MA, Gupta AK,. Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 241-2.
4. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361: 496-509.
5. Icen M, Crowson CS, McEvoy MT, et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 2009; 60: 394-401.
6. Tollefson MM, Crowson CS, McEvoy MT, Maradit Kremers H,. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol 2010; 62: 979-87.
7. Huerta C, Rivero E, Rodriguez LA,. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-65.
8. Vena GA, Altomare G, Ayala F, et al. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol 2010; 20: 593-8.
9. Kurd SK, Gelfand JM,. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009; 60: 218-24.
10. Lima XT, Minnillo R, Spencer JM, Kimball AB,. Psoriasis prevalence among the 2009 AAD National Melanoma/Skin Cancer Screening Program participants. J Eur Acad Dermatol Venereol 2012. doi:10.1111/j.1468-3083.2012.04531.x. [Epub ahead of print].
11. Jagou M, Bastuji-Garin S, Bourdon-Lanoy E, et al. Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses. Br J Dermatol 2006; 155: 1006-12.
12. Plunkett A, Merlin K, Gill D, et al. The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia. Int J Dermatol 1999; 38: 901-8.
13. Jensen P, Thyssen JP, Zachariae C, et al. Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study. Int J Dermatol 2012. doi:10.1111/j.1365-4632.2011.05408.x. [Epub ahead of print].
14. Bo K, Thoresen M, Dalgard F,. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatology 2008; 216: 40-5.
15. Landgren E, Braback L, Hedlin G, et al. Psoriasis in Swedish conscripts: time trend and association with T-helper 2-mediated disorders. Br J Dermatol 2006; 154: 332-6.
16. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-41.
17. Christophers E,. Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 2001; 26: 314-20.
18. Gudjonsson JE, Elder JT,. Psoriasis: epidemiology. Clin Dermatol 2007; 25: 535-46.
19. Higgins E,. Alcohol, smoking and psoriasis. Clin Exp Dermatol 2000; 25: 107-10.
20. Naldi L,. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004; 3: 121-8.
21. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM,. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013; 133: 377-85.
22. Gervin K, Vigeland MD, Mattingsdal M, et al. DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet 2012; 8: e1002454.
23. Zhang P, Su Y, Lu Q,. Epigenetics and psoriasis. J Eur Acad Dermatol Venereol 2012; 26: 399-403.
24. Kavli G, Førde OH, Arnesen E, Stenvold SE,. Psoriasis: familial predisposition and environmental factors. Br Med J (Clin Res Ed) 1985; 291: 999-1000.
25. Jacobsen BK, Eggen AE, Mathiesen EB, et al. Cohort profile: the Tromsø Study. Int J Epidemiol 2012; 41: 961-7.
26. Palmore E,. When can age, cohort and period be separated? Soc Forces 1978; 57: 282-95.
27. Ahacic K, Kareholt I,. Prevalence of musculoskeletal pain in the general Swedish population from 1968 to 2002: age, period, and cohort patterns. Pain 2010; 151: 206-14.
28. Farber EM, Nall ML,. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148: 1-18.
29. Griffiths CE, Barker JN,. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-71.
30. Brandrup F, Green A,. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981; 61: 344-6.
31. Setty AR, Curhan G, Choi HK,. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med 2007; 167: 1670-5.
32. Icen M, Crowson CS, McEvoy MT, et al. Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol 2008; 59: 981-5.
33. Olsen AO, Grjibovski A, Magnus P, et al. Psoriasis in Norway as observed in a population-based Norwegian twin panel. Br J Dermatol 2005; 153: 346-51.
34. Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-8.
35. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Invest Dermatol Symp Proc 2004; 9: 136-9.
36. Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005; 52: 23-6.
37. Chandran V, Raychaudhuri SP,. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 2010; 34: J314-21.
38. Hellgren L,. Psoriasis. The Prevalence in Sex, Age and Occupational Groups in Total Populations in Sweden. Morphology, Inheritance and Association with other Skin and Rheumatic Diseases. Stockholm: Almqvist & Wiksell, 1967.
39. Ferrandiz C, Pujol RM, Garcia-Patos V, et al. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002; 46: 867-73.
40. Braathen LR, Botten G, Bjerkedal T,. Prevalence of psoriasis in Norway. Acta Derm Venereol Suppl (Stockh) 1989; 142: 5-8.
41. Duffy DL, Spelman LS, Martin NG,. Psoriasis in Australian twins. J Am Acad Dermatol 1993; 29: 428-34.
42. Raychaudhuri SP, Farber EM,. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 2001; 15: 16-17.
43. Soyland E, Heier I, Rodriguez-Gallego C, et al. Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol 2011; 164: 344-55.
44. Farber EM, Nall L,. Psoriasis and ultraviolet radiation. Cutis 1993; 52: 145-52.
45. Schauber J, Gallo RL,. The vitamin D pathway: a new target for control of the skin's immune response? Exp Dermatol 2008; 17: 633-9.
46. Gisondi P, Rossini M, Di Cesare A, et al. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012; 166: 505-10.